Markets

Markets Overview Market Context

Briefs Calendar

Research

News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Market Context Briefs Calendar News Search AI Market Assistant Charts & News Instrument directory Macro Politics Prediction Markets News Archive Account

Home News ArchivePrysmian Completes Acquisition of Atkore

Live News MNA FLASH M impact Oct 19, 2026, 12:44 PM UTC

Prysmian Completes Acquisition of Atkore

SquawkNews Desk

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

PRY

Related stories

Roche and Hansoh Sign Cancer Drug Licensing Deal Worth Up to $15 Billion Roche entered a collaboration and licensing agreement with China's Hansoh for a portfolio of targeted cancer drugs. The deal could exceed $15 billion. M impact | MNA | Oct 19, 2026, 01:38 PM UTC GoPro Files Preliminary Proxy Statement for Proposed Starman Optical Merger GoPro filed a preliminary proxy statement, and its proposed merger with Starman Optical remains on track. L impact | MNA | Oct 19, 2026, 01:22 PM UTC Data I/O Announces Proposed $13.25M Offering and About $23M Acquisition Data I/O announced a proposed $13.25 million private securities offering and a definitive agreement to acquire V-TEK and A&J Programming for about $23 million. M impact | MNA | Oct 19, 2026, 01:03 PM UTC Qassim Cement Completes Acquisition of 100% of A-Mix Shares M impact | MNA | Oct 19, 2026, 12:56 PM UTC H.B. Fuller Rejects Ancora Bid, Considers Selling Non-Core Businesses H.B. Fuller’s board unanimously rejected Ancora’s latest offer to acquire its building adhesives solutions business. The company said it would consider separating certain businesse M impact | MNA | Oct 19, 2026, 12:48 PM UTC Merck Agrees to Buy Silence Therapeutics for $1.3 Billion Merck KGaA said it is offering $20 per American depositary share in cash for the U.K. biotech, adding an experimental polycythemia vera medicine to its pipeline. M impact | MNA | Oct 19, 2026, 12:45 PM UTC

SQUAWK/NEWS

Independent financial newsroom. Editorial expertise and proprietary AI. Paid LiveCast brings live headlines, chart context and priority audio to your trading day. Free research tools remain available.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

News & Research

Open LiveCast
Session Briefs
Market Context
Macro
Politics
Prediction Markets
News Archive

Markets & Tools

Charts & News
Markets Overview
US Stocks
Market Movers
Economic Calendar
Policy Calendar
AI Market Assistant
News Search
Instrument Directory

Guides

Charts & News Guide
How LiveCast Works
What Is an Audio Squawk?
Why News Moves Markets
News for Traders
How to Trade the News

Plans & API

Plans & Pricing
Institutional API
RSS Feed

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

© 2026 SquawkNews

Privacy Policy Terms of Use

SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.